Israel Englander’s Array Biopharma Inc ARRY Stock Holding History

Israel Englander’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-170,500	Closed	-$2.78M	–	4396
2018 Q1	$2.78M	Buy	+170,500	New	+$2.73M	﹤0.01%	2141
2016 Q4	–	Sell	-400,000	Closed	-$2.7M	–	3922
2016 Q3	$2.7M	Buy	+400,000	New	+$1.55M	﹤0.01%	1742

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Israel Englander's ARRY Position: Q3 2019 in Review

Israel Englander sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 3,021,920 shares — an estimated $140M sold.

Israel Englander first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $140M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Israel Englander reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Israel Englander sold 3,021,920 Array Biopharma Inc shares in Q3 2019, an estimated $140M.
Israel Englander first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
Israel Englander's Array Biopharma Inc position peaked at $140M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Millennium Management's 13F filing for Q3 2019, filed 14 Nov 2019.